
Cautious Approach Continues in China: PE deal
activity remains slow, signaling sustained challenges that
could persist into 2025, which will remain a buyers’ market.
Momentum Continuing in Globalizing Sectors:
Despite potential impact from US tariffs, deal activity
and investments in resilient sectors where China has
demonstrated global competitiveness and benefited from
global collaboration, including EVs, clean technology, energy
and resources, and healthcare, are expected to grow. The
recent exclusion of the Biosecure Act from the US defense
bill is a significant win for Chinese biotech companies, as it
prevents them from being blacklisted from new US federally
funded research and contracts and maintains their access
to the US markets and collaborations.
Control Deals Gain Popularity: Popularity of control
deals rises as PE firms seek greater influence over value
creation and efficiency enhancement and control over exits.
Focus on Operational Efficiencies: PE firms prioritize
operational improvements to enhance portfolio company
value, especially amid shrinking exit options. Efficiency-
driven strategies could remain central in 2025 to maximize
returns.
Chinese GPs Eye Global Growth: Chinese GPs
emphasize a global strategy and expanding overseas
to enable portfolios’ global expansion and diversify deal
exposure, a trend that could be critical for growth amid
domestic and geopolitical challenges.
China
Growth in Alternative Asset Classes: Continued growth
in alternative assets, driven by a search for stable, long-
term returns amidst economic uncertainty. Southeast Asia
benefits as allocations grow in sectors like private credit,
infrastructure, logistics, and renewable energy.
Healthcare Sector Momentum Sustained: Healthcare,
particularly medical tech, health services, and Insurtech,
remains a key growth sector, driven by the region’s growing
middle class, increasing demand for quality healthcare, and
advancements in digital health and biotechnology.
Local Regulatory Challenges and Anti-Monopoly
Scrutiny: Regulatory scrutiny, especially in the tech sector,
will intensify in 2025, as anti-monopoly actions and stricter
enforcement take center stage in Indonesia and Vietnam,
Southeast Asia’s high-growth markets.
Hopeful Ease for Exit Backlogs: The backlog of exits is
expected to ease by mid-2025, as interest rates stabilize
and IPO markets recover. Despite short-term constraints in
the exit environment, secondary buyouts and continuation
funds continue to provide flexibility for PE firms.
Geopolitical Risks and and Opportunities: Intensifying
geopolitical risks will shape deal activity. SEA’s geopolitical
neutrality will create opportunities in supply chain industries,
but escalating tensions may complicate dealmaking.
Investments in key industries will require funds to navigate
ongoing changes in global trade rules.
Southeast Asia
Japan Investment Fueled by Multiple Factors:
Japanese M&A volume and PE dealmaking are at record
levels, with foreign investor interest increasing as a result
of several factors, including a weaker yen, low interest
rates, strong supply, a shift in capital away from China, and
Japan corporates looking to unlock shareholder value and
increase price-to-book ratios.
Increase in Unsolicited Offers and Competing Bids:
Historically in Japan, hostile takeovers have been viewed
negatively and Japanese mega banks were very hesitant
to finance these deals. However, perceptions appear to be
changing after the Japanese government published new
M&A Guidelines. Well-known Japanese strategic buyers are
increasingly willing to explore and launch unsolicited offers.
PE firms appear likely to follow suit as competition grows
for attractive acquisition targets.
PE Acquisition Focus: Carve-out deals, buyouts
from founders, and growth equity investments in late-
stage startups continue to attract significant interest
from buyout funds. Hot sectors include semiconductor-
related businesses, automotive parts manufacturers, and
electronics and life sciences companies.
Japan
Favorable Investment Environment: Relaxed foreign
direct investment (FDI) restrictions, tax reforms, and
supportive policies continue attracting foreign sponsors
from the US, Singapore, and the Middle East. These
investors are expanding local teams and increasing
exposure in India’s high-growth sectors, such as consumer,
healthcare, infrastructure, and real estate.
Diversified Exit Channels: While IPO and public
market sale remain the dominant exit routes for investors,
secondary buyouts by mega funds and strategic sales
are gaining traction, driven by portfolio companies’ strong
growth potential and attractive yields.
Valuation: Despite rising interest rates and geopolitical
uncertainties, the valuations of Indian companies remain
at premium levels compared to global peers due to
bullish public market sentiment, fierce competition among
domestic and foreign funds for quality assets, abundant
dry powder, and optimistic growth expectations. Foreign
investors are increasingly focusing on robust business
models and proven financial performance, rather than
chasing high valuations.
Local Partnerships Are Key: As a challenging
fundraising environment will likely continue into 2025,
those foreign investors that have established a local
presence and can leverage their networks with local
operators with extensive sectoral knowledge will likely
see more opportunities and thus be able to execute more
investments than those without strong local partners.
India
5
Regional Perspective for 2025